Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BORTEZOMIB vs BOSUTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BORTEZOMIB vs BOSUTINIB: Safety Overview

Metric BORTEZOMIB BOSUTINIB
Total FAERS Reports 47,710 7,777
Deaths Reported 7,318 680
Death Rate 15.3% 8.7%
Hospitalizations 14,626 1,675
Average Patient Age 64.1 yrs 64.7 yrs
% Female Patients 44.5% 51.8%
FDA Approval Date Aug 26, 2024 May 23, 2025
Manufacturer Hikma Pharmaceuticals USA Inc. U.S. Pharmaceuticals
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription